Fresenius Medical Care AG(FMS) - 2023 Q4 - Earnings Call Presentation

▪ Solid organic revenue growth driven by both operating segments 4 2023 – Payors favor home treatments Investor Relations │ Analyst Presentation Q4 2023 Page 11 Low priority on M&A activities 2 Q4 Business Update Outlook Q4 2023 | Key developments at Group level ▪ Broadly stable U.S. same market treatment growth ▪ Operating income (outlook base) increased due to strong FME25 savings, the Tricare settlement and pricing in Care Enablement ▪ Realization of FME25 savings continued ahead of plan ▪ Value-based ca ...